MORGAN STANLEY PLC/PUT/MEDTRONIC/80/0.1/20.09.24 Share Price

Warrant

DE000ME4FU15

Market Closed - Börse Stuttgart 19:17:27 05/07/2024 BST
0.36 EUR -5.26% Intraday chart for MORGAN STANLEY PLC/PUT/MEDTRONIC/80/0.1/20.09.24
Current month+24.14%
1 month+52.54%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
05/07/24 0.36 -5.26%
04/07/24 0.38 -7.32%
03/07/24 0.41 -2.38%
02/07/24 0.42 +10.53%
01/07/24 0.38 +31.03%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 07:17 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN ME4FU1
ISINDE000ME4FU15
Date issued 01/12/2023
Strike 80 $
Maturity 20/09/2024 (76 Days)
Parity 10 : 1
Emission price 0.64
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.62
Lowest since issue 0.149
Delta-0.56x
Omega 10.90
Premium2.02x
Gearing19.61x
Moneyness 1.031
Difference Strike 2.39 $
Difference Strike %+2.99%
Spread 0.01
Spread %2.70%
Theoretical value 0.3650
Implied Volatility 21.95 %
Total Loss Probability 40.50 %
Intrinsic value 0.2205
Present value 0.1445
Break even 76.04 €
Theta-0.01x
Vega0.01x
Rho-0.01x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.61 USD
Average target price
94.02 USD
Spread / Average Target
+21.15%
Consensus